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NK cells are critical mediators of host immunity to malignancy and viral infection. Activation of NK cells is primarily controlled by germ line-encoded surface receptors that recognize self-encoded or virally encoded molecules expressed on infected or stressed cells and by proinflammatory cytokines, such as interleukin 12 (IL-12), IL-18 and type I interferons (IFNs). Activated NK cells respond by proliferating and by rapidly secreting cytokines such as IFN-γ and tumor necrosis factor (TNF) and cytotoxic molecules (perforin and granzyme B) that lyse infected or malignant target cells 1 .
Although classically NK cells have been considered cells of the innate immune system, they are now appreciated to have a number of developmental and effector function features in common with T cells and B cells of the adaptive immune system. Similarities include development from a common lymphoid progenitor cell, a requirement for common γ-chain-dependent cytokines (for example, IL-15 and IL-7) during development and homeostasis, and an education process in the bone marrow that is analogous to T cell development in the thymus 1 . Moreover, much like their B cell and T cell counterparts, which use the B cell antigen receptor and T cell antigen receptor (TCR), respectively, to recognize antigens, NK cells also express activating receptors capable of directly binding foreign, often virally derived, antigens. For example, in C57BL/6 mice, the activating receptor Ly49H binds the mouse cytomegalovirus (MCMV)-encoded glycoprotein m157 (refs. 2,3); receptor-ligand engagement drives a proliferative 'burst' and effector response that is both necessary and sufficient for resistance to MCMV in this mouse strain [4] [5] [6] [7] . Kinetics of the Ly49H + NK cell response to MCMV infection are highly reminiscent of antigen-specific B cell and T cell responses. Most notably, the primary response, which peaks in cell number at around day 7 after infection 7, 8 , contracts into a long-lived pool of antigen-specific NK cells that exhibit many features of immunological 'memory' , including long-term persistence and enhanced functionality upon antigen rechallenge 8 .
Broad complex, Tramtrack, Bric á brac and zinc finger (BTB-ZF) proteins are a large family of transcription factors with important roles in development, differentiation and oncogenesis 9 . Family members are characterized by the presence of C-terminal C 2 H 2 Krüppel-type zinc finger domains, which facilitate sequence-specific DNA binding at target loci, and an N-terminal BTB domain that recruits co-repressors and histone modification enzymes to the site of regulation 9, 10 . BTB-ZF proteins are currently thought to act primarily as repressors of target gene transcription, in part by modifying chromatin accessibility at target loci.
A growing number of studies have revealed an essential and nonredundant role for BTB-ZF proteins in the regulation of lineage commitment, development and effector function in lymphocytes 10 . Examples include LRF, which controls T cell versus B cell commitment 11 ; MAZR and ThPOK, which direct CD8 + and CD4 + T cell lineage commitment, respectively [12] [13] [14] [15] [16] ; PLZF, which regulates the development and function of NKT and γδ T cells [17] [18] [19] [20] ; and Bcl-6, which is required for formation of germinal-center B cells and follicular T helper cells [21] [22] [23] [24] [25] . The extent to which BTB-ZF proteins regulate NK cell development and function is largely unknown. Given their prominent role in T cell and B cell biology, we hypothesized that BTB-ZF proteins may act as important regulators of the adaptive lymphocyte-like features of NK cells. Here we identify the BTB-ZF transcription factor Zbtb32 as an essential regulator of the proliferative burst of MCMV-specific NK cells in response to viral infection in vivo and show that Zbtb32 is required for NK cell-mediated protection against lethal viral challenge.
RESULTS

MCMV infection induces Zbtb32 expression in NK cells
To identify BTB-ZF genes that might regulate antigen-specific NK cell responses, we first compared expression of 47 BTB-ZF genes in sorted Ly49H + NK cells from MCMV-infected and uninfected mice by microarray. Only three (Zbtb32, Hic1 and Bcl6) were significantly modulated in NK cells on day 1.5 after infection, and of these three, Zbtb32 was the most highly upregulated (Fig. 1a) . Of the >35,000 genes evaluated on the microarray (Gene Expression Omnibus: GSE15907) 26 , Zbtb32 was among the top 30 most highly induced on day 1.5 after infection (Fig. 1b) . We confirmed the microarray data by quantitative reverse-transcription (qRT)-PCR, which revealed a >100-fold upregulation of the Zbtb32 transcript in Ly49H + NK cells on day 2 after infection with MCMV (Fig. 1c) , and by flow cytometry, which showed elevated Zbtb32 protein expression on days 2 and 3 after infection (Supplementary Fig. 1 ). Expression of Zbtb32 transcript and protein were transient, and both returned to baseline abundance by day 4 after infection, which suggested an equally rapid downregulation of this transcription factor after its induction during viral infection.
Zbtb32 is required for NK cell antiviral immunity
Given its rapid upregulation after viral infection, we hypothesized that Zbtb32 might regulate the function and/or phenotype of activated antigen-specific NK cells. It has been shown previously that adoptively transferred Ly49H + NK cells can rescue NK cell-deficient or -impaired mice from otherwise fatal doses of MCMV 8 . To test the protective capacity of Zbtb32 −/− NK cells, we transferred Ly49H + wild-type or Zbtb32-deficient NK cells into neonate mice, which lack mature B cells, T cells and NK cells and are highly susceptible to viral infection, and assessed the ability of the transferred cells to protect against lethal MCMV challenge 8, 27 . As expected, wild-type Ly49H + NK cells had a significantly protective effect, with 33% of mice surviving past 3 weeks (median survival of 15 d; Fig. 2a ). In contrast, neonates receiving Zbtb32 −/− NK cells died early after infection (median survival of 8 d), similar to control animals that did not receive NK cells. To confirm the requirement for Zbtb32 in protective NK cell responses, we compared the ability of wild-type and Zbtb32 −/− Ly49H + NK cells to protect adult Ly49H-deficient mice against lethal doses of recombinant vesicular stomatitis virus (VSV) expressing the MCMV-derived m157 protein (VSV-m157). In this model, mice infected with VSV-m157 rapidly succumb to paralysis and death in the absence of transferred Ly49H + NK cells. Whereas adoptively transferred wild-type Ly49H + NK cells protected ~50% of infected mice from death, all recipients of Zbtb32 −/− Ly49H + NK cells died rapidly after infection, at a time comparable to animals that did not receive NK cells (Fig. 2b) . Thus, Zbtb32 is required for protective antiviral responses by antigen-specific NK cells.
Zbtb32 is dispensable for NK cell activation and function NK cells respond to MCMV infection by rapidly producing cytolytic proteins and proinflammatory cytokines, and for the subset of NK cells that express the Ly49H receptor, by proliferating to enlarge the overall pool of effector cells 1, 7 . Given the protective defect of Zbtb32 −/− NK cells, we sought to delineate which of these effector functions was controlled by Zbtb32. Zbtb32 has previously been shown to suppress cytokine production in activated T cells [28] [29] [30] [31] [32] . Zbtb32 −/− CD4 + T cells exhibited elevated expression of cytokines associated with type 2 helper T cells (T H 2 cells), including IL-4, IL-5 and IL-13, after activation in vitro 29 or in the context of allergen-induced models of airway and contact hypersensitivity in vivo 31, 32 . Similarly, activated Zbtb32 −/− CD8 + T cells produced more IFN-γ than their wild-type counterparts 29 . In contrast to the findings in T cells, Zbtb32 −/− and wild-type NK cells were indistinguishable in their ability to produce IFN-γ in response to MCMV infection in vivo (Fig. 3a) , and after stimulation in vitro with proinflammatory cytokines or via cross-linking of activating receptors (Supplementary Fig. 2a) . Furthermore, wild-type and Zbtb32 −/− NK cells from MCMV-infected mice similarly upregulated expression of the potent cytotoxic protein granzyme B (Fig. 3b) and CD107a, a marker of degranulation (data not shown). In addition, NK cells in Zbtb32 −/− mice were similar to those in wild-type animals with respect to their ability 
Tex2 Ifng to kill adoptively transferred target cells (Supplementary Fig. 2b ).
After MCMV infection, wild-type and Zbtb32 −/− NK cells were comparable with respect to expression of the activation markers CD69 and KLRG1 (Fig. 3c) , and both populations exhibited similar conversion to fully mature CD27 lo CD11b hi cells by day 7 after infection ( Fig. 3d) . Taken together, our data indicate that the protective deficiency of Zbtb32 −/− NK cells does not stem from a defect in killing capacity, cytokine production or maturation after viral infection.
Cell-intrinsic requirement for Zbtb32 in NK cell expansion Given that effector responses were largely intact in Zbtb32-deficient NK cells, we postulated that their protective defect may arise from an impairment in antigen-driven proliferation. To test this hypothesis, we co-transferred equal numbers of Zbtb32 −/− and wild-type Ly49H + NK cells into Ly49H-deficient hosts and evaluated the ability of the transferred Ly49H + cells to expand after MCMV infection ( Supplementary  Fig. 3a) . Whereas the transferred wild-type Ly49H + NK cell population rapidly expanded and reached peak numbers and percentages in the spleen by day 7 after infection, transferred Zbtb32 −/− Ly49H + NK cells were barely detectable at that time point (Fig. 4a,b) . We obtained similar results when we transferred Zbtb32 −/− and wild-type Ly49H + NK cells separately ( Fig. 4c) , which indicated that wild-type NK cells were not simply outcompeting their Zbtb32-deficient counterparts.
The low numbers and percentages of Zbtb32 −/− NK cells in the spleen were not due to aberrant trafficking, because we observed a similar deficiency in the liver, lymph node and lung (Fig. 4d) . Moreover, the relative percentages of wild-type and Zbtb32 −/− NK cells (~95% versus ~5%) remained constant from day 5 through day 45 after infection, ruling out delayed population expansion kinetics and a role for Zbtb32 in memory NK cell formation and maintenance (Fig. 4e) .
The requirement for Zbtb32 in antigen-specific NK cell expansion was not limited to MCMV infection, because the Zbtb32 −/− Ly49H + NK cell population also exhibited an expansion defect after infection with m157-expressing VSV or m157-expressing VacV, although the magnitude of this defect was directly proportional to the number of cellular divisions driven by each virus (Fig. 4f and data not shown).
To test whether there exists a gene-dosage effect for Zbtb32 in antiviral NK cell responses, we individually co-transferred NK cells from Zbtb32 −/− , Zbtb32 +/− or Zbtb32 +/+ littermates along with congenic wild-type NK cells into Ly49H-deficient hosts. As expected, the Ly49H + NK cell population from Zbtb32 +/+ mice expanded as well as that from wild-type donors, whereas the Ly49H + NK cell population from Zbtb32 −/− littermates barely expanded at all, which confirmed that Zbtb32 deficiency, and not background-related effects, was responsible for the expansion defect ( Fig. 4g) . To our surprise, Ly49H + NK cells containing only one Zbtb32 allele (Zbtb32 +/− ) were almost as dysfunctional as fully deficient Zbtb32 −/− NK cells, which underscored that maximal Zbtb32 expression is required for expansion of the NK cell population after infection.
Because Zbtb32 is also upregulated in antigen-specific CD8 + T cells after viral or bacterial infection (data not shown), and has previously been reported to regulate T cell proliferation in vitro (although these studies suggested a restrictive role for Zbtb32 in TCR-driven proliferation) 29, 33 , we measured the expansion of antigen-specific CD8 + T cells in wild-type:Zbtb32 −/− mixed bone marrow chimeras during MCMV infection (Fig. 4h) . In contrast to our findings in NK cells, Zbtb32-deficient antigen-specific CD8 + T cell populations expanded similarly or better than their wild-type counterparts. Thus, taken together, our data indicate an essential cell-intrinsic and lineage-specific function for Zbtb32 in promoting NK cell expansion after infection. npg with division-tracking dye CFSE confirmed that Zbtb32 deficiency markedly impaired MCMV-driven proliferation in vivo (Fig. 5a) . The impaired proliferative capacity of Zbtb32 −/− Ly49H + NK cells was corroborated by their decreased expression of the proliferation marker Ki67 (Fig. 5b) and by their inability to incorporate 5-bromodeoxyuridine (BrdU) after short-term pulses on days 4 and 6 after infection (Fig. 5c ). This defect was mirrored at a molecular level by a failure of Zbtb32-deficient NK cells to upregulate genes involved in cell-cycle progression (Fig. 5d) . Because Zbtb32 was upregulated to a similar extent in both Ly49H + and Ly49H − NK cells after infection (Supplementary Fig. 3b) , we tested whether Zbtb32 might also regulate the low-level NK cell proliferation that occurs independently of Ly49H-m157 engagement. Indeed, even Ly49H − NK cells showed impaired proliferation in the absence of Zbtb32, as did Ly49H + NK cells responding to infection with MCMV ∆m157 (Supplementary Fig. 3c,d ), although this defect was subtle given that all NK cells proliferated very little in these settings.
Zbtb32 controls NK cell proliferation but not survival
In contrast to their proliferation defect, Zbtb32 −/− NK cells exhibited no evidence of enhanced apoptosis by staining for annexin V, the proapoptotic molecule Bim or activated caspases (Fig. 5e and data not shown). In T cells, the prosurvival protein Bcl-2 is downregulated in effector cells with the highest proliferative capacity, and subsequent apoptosis of these highly proliferative Bcl-2 lo cells marks the contraction phase of the effector T cell response 34, 35 . Consistent with a defect in proliferation but not survival, Zbtb32 −/− NK cells failed to undergo activation-induced downregulation of Bcl-2 ( Fig. 5f) . Thus, these findings highlight a specific requirement for Zbtb32 in the proliferation but not survival of NK cells after viral infection.
Zbtb32 is dispensable for development and homeostasis
The NK cell compartment of Zbtb32 −/− mice was phenotypically indistinguishable from that of wild-type animals, which suggested that Zbtb32 deficiency neither impaired development of NK cells nor abrogated proliferation in that context. The percentage and number of mature NK cells in peripheral organs and of NK cell developmental subsets in the bone marrow of Zbtb32-deficient mice was comparable to that observed in wild-type animals ( Supplementary Fig. 4a,b and data not shown). Similarly, NK cells in Zbtb32 −/− mice expressed normal amounts of markers typically associated with NK cell identity and function, including Ly49H, Ly49D, NK1.1, DX5, Ly49C or Ly49I and Ly49A (Supplementary Fig. 4c,d) .
In addition, wild-type and Zbtb32-deficient NK cells repopulated the hematopoietic compartment of mixed bone marrow chimeric mice with similar efficiencies (Supplementary Fig. 5 ), confirming that Zbtb32 was dispensable for NK cell development. However, when we adoptively transferred wild-type and Zbtb32 −/− Ly49H + NK cells from mixed bone marrow chimeric mice into naive Ly49H-deficient recipients, only the wild-type population expanded after MCMV challenge, which reaffirmed that even Zbtb32 −/− NK cells that developed in a Zbtb32-sufficient environment exhibited an expansion defect after infection ( Supplementary  Fig. 5 ). Consistent with a dispensable role in NK cell proliferation during development, Zbtb32 −/− NK cells exhibited normal homeostatic proliferation when transferred into lymphocyte-deficient hosts (Fig. 5g) and when expanded ex vivo with IL-2 and IL-15, cytokines important for proliferation and survival of NK cells during development and at steady state (Fig. 5h) . Thus, Zbtb32 does not appear to be necessary for NK cell proliferation in a noninflammatory environment. Collectively, our data indicate that Zbtb32 is dispensable for development and , representative of n = 4 mice per group from two independent experiments (c), cumulative from three independent experiments (d), cumulative for five independent experiments, n = 10 (day 3), n = 6 (day 4), n = 4 (day 5), n = 8 (day 6), n = 5 (day 7), n = 2 (day 8) and n = 9 (day 45) (e), representative of at least two independent experiments (f), representative of n = 3 mice per group in each of two independent experiments (g), and representative of three independent experiments (h). All error bars, s.e.m.
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A r t i c l e s homeostasis-associated proliferation but rather specifically regulates proliferation of NK cells in the context of an infectious or inflammatory setting.
Inflammation drives Zbtb32 expression in NK cells
Because we observed maximal levels of Zbtb32 mRNA in NK cells at early time points in vivo (by ~48 h after infection), when inflammation is high but viral dissemination (and thus antigen availability) is still lagging, and because both Ly49H + and Ly49H − NK cells upregulated Zbtb32 after infection, we hypothesized that signals from proinflammatory cytokines, rather than interactions between the Ly49H receptor and the m157 viral antigen, might control Zbtb32 expression in activated NK cells. Indeed, in resting NK cells stimulated ex vivo, the proinflammatory cytokines IL-12, IL-18 or IFN-α/β induced high expression of Zbtb32 mRNA, with IL-12 and IL-18 cotreatment exerting a strongly synergistic effect (Fig. 6a) (Fig. 6b) . Given that proinflammatory cytokines induce Zbtb32, we postulated that specific transcriptional activators downstream of cytokine receptors might directly regulate Zbtb32 expression in NK cells. Analysis of the Zbtb32 promoter revealed several conserved noncoding sites (CNSs) in a DNase I hypersensitivity region previously identified in human NK cells 36 (Fig. 6c) . Chromatin immunoprecipitation (ChIP) experiments showed enrichment of acetylated histone marks at these sites (specifically, H3K27Ac, which marks transcriptionally active promoters), consistent with a likely role in transcriptional activation of Zbtb32 (Fig. 6d) . In support of direct regulation by cytokine receptor signaling, the CNS regions of the Zbtb32 promoter harbor putative binding sites for the transcription factor STAT4, which acts downstream of the IL-12 receptor to induce target gene expression in lymphocytes (Fig. 6c) . Similar to the case in IL-12R-deficient NK cells, NK cells lacking STAT4 were also significantly impaired in MCMV-induced Zbtb32 expression (Fig. 6e) . Using STAT4 ChIP, we observed substantial binding of STAT4 at a CNS in the Zbtb32 promoter ~750 base pairs upstream of the transcriptional start site, which indicated that Zbtb32 may be a direct target of STAT4, acting as a transmitter of IL-12 signaling (Fig. 6f) . Decreased Zbtb32 expression correlates with the impaired proliferation recently observed in IL-12R-or STAT4-deficient NK cells 37 , consistent with a central role for Zbtb32 in transmitting proproliferative signals downstream of inflammatory cues. Thus, signals from proinflammatory cytokines, but not activating receptors, are sufficient to induce and are required for maximal Zbtb32 expression in primary NK cells.
Zbtb32 promotes proliferation by antagonizing Blimp-1
We next sought to identify the specific pathway(s) regulated by Zbtb32 in proliferating NK cells. Zbtb32 deficiency did not affect expression or phosphorylation of STAT1, STAT3, STAT4 or T-bet in activated NK cells, transcription factors with proven or suspected roles in NK cell effector function [37] [38] [39] , nor did it influence expression of Gata3, a known target of Zbtb32 in T cells 28, 30 (Supplementary Fig. 6a ). These data are consistent with our findings that the nonproliferative features of NK cell activation, including production of IFN-γ and cytotoxic molecules, are intact in the absence of Zbtb32. Because cell-cycle genes are dysregulated in Zbtb32 −/− NK cells during MCMV infection (Fig. 5d) , we investigated the mechanism(s) by which Zbtb32 may promote cell-cycle progression in NK cells. In T cells and B cells, proliferation of effector lymphocytes (for example, germinal center B cells) depends on suppression of the antiproliferative/proterminal differentiation factor, Blimp-1 (encoded by Prdm1) 40 . Blimp-1 is upregulated in NK cells during development, where it functions to restrict proliferation, and remains highly expressed in mature resting NK cells. Although the BTB-ZF protein Bcl-6 is the main antagonist of Blimp-1 in B cells and T cells 40 , it does not have this role in developing NK cells 41 and is unlikely to do so in activated NK cells, because Bcl-6 is actually downregulated after infection (Fig. 1b  and Supplementary Fig. 6b ). Given the high degree of homology between Bcl-6 and Zbtb32, we hypothesized that Zbtb32 rather than Bcl-6 may function in activated NK cells to suppress expression or function of Blimp-1 and thereby facilitate antigen-driven proliferation. This idea was supported by a recent report that showed a physical interaction between Zbtb32 and Blimp-1 in B cells 42 and our own observation that Prdm1 expression was elevated in Zbtb32 −/− Ly49H + NK cells (Fig. 7a) . However, to formally test this hypothesis, we generated mice harboring NK cells in which both Zbtb32 and Prdm1 were genetically deleted, by crossing Zbtb32 −/− mice to mice carrying Prdm1 alleles flanked by loxP sites (Prdm1 fl/fl ) and mice containing the Cre recombinase driven from the NKp46 promoter (Nkp46-Cre + ). We predicted that if the primary function of Zbtb32 was to suppress or antagonize Blimp-1 function, then deletion of Blimp-1 in Zbtb32-deficient NK cells should result in a partial or complete restoration of Ly49H + NK cell expansion during MCMV infection. Indeed, we found that whereas NK cells from Zbtb32 −/− Prdm1 fl/fl Nkp46-Cre − (Zbtb32-deficient only) donors were severely impaired in their ability to expand after infection, NK cells from Zbtb32 −/− Prdm1 fl/fl Nkp46-Cre + (Zbtb32 and Blimp-1 double-deficient) littermates were fully rescued from this defect and proliferated as well as wild-type cells (Fig. 7b,c) . Thus, consistent with our hypothesis, Zbtb32 was no longer required for MCMV-driven NK cell proliferation when Blimp-1 was not present. These findings provide a molecular explanation for how Zbtb32 acts downstream of proinflammatory signals to promote a proproliferative state in activated NK cells, and reveal an antagonistic interaction between Zbtb32 and Blimp-1 that regulates NK cell expansion during infection (Supplementary Fig. 7 ).
DISCUSSION
A growing number of recent studies in mice and humans have led to the unexpected discovery that NK cells can mount antigenspecific responses with features of adaptive immunity, including robust clonal proliferation, long-term persistence and enhanced secondary responses of virus-specific NK cells 1 . Before now, the molecular events that regulate these antigen-specific responses were almost completely unknown. Here we demonstrated that the transcription factor Zbtb32 is essential for the proliferation and protective functionality of MCMV-specific NK cells responding to infection. Zbtb32 deficiency ablated the proliferative burst of antigen-specific NK cells and impaired the low-level proliferation driven by antigen-independent signals in 'bystander' NK cells. We also showed that signals from proinflammatory cytokines were necessary and sufficient to induce Zbtb32 expression in activated NK cells. At a mechanistic level, Zbtb32 promoted a proproliferative state in activated NK cells by antagonizing the tumor suppressor factor, Blimp-1. In summary, in this study we elucidated the molecular pathway behind the proliferative burst of antigen-specific NK cells and demonstrated not only that Zbtb32 is the molecular 'link' between inflammation and proliferation in NK cells but also revealed a previously uncharacterized antagonistic interaction between Zbtb32 and Blimp-1.
The finding that proinflammatory cytokines are essential for maximal Zbtb32 expression provides a mechanistic explanation for how and why inflammatory signals are required for the robust proliferation of antigen-specific NK cells during MCMV infection, even when high amounts of viral antigen are available 37 . This pathway may be analogous to 'signal 3' in the widely accepted model of T cell activation, which holds that full effector function relies on three independent and cotemporal signals from the TCR (signal 1), co-stimulatory receptors such as CD28 (signal 2), and cytokine receptors such as IFNAR and IL-12R (signal 3). In a similar manner, inflammationdriven upregulation of Zbtb32 may act as an important checkpoint for effector responses by NK cells, only allowing robust antigen-driven proliferation when clear signals of infection are present. Indeed, the intimate connection between inflammation and Zbtb32 expression is consistent with our finding that Zbtb32 is dispensable for NK cell proliferation in noninflammatory settings, such as during development, homeostatic turnover and long-term maintenance of memory cells.
During infection, both IL-12 signaling (for example, as reflected by STAT4 phosphorylation) and Zbtb32 expression peak early after infection, yet this pathway has a critical, long-lasting impact on the proliferative response that continues for days after these initiating signals have returned to baseline. These findings are consistent with a model in which Zbtb32 acts as a 'priming' signal in inflammationactivated NK cells, suppressing Blimp-1 function and thereby unleashing a long-lasting proliferative potential in antigen-specific and nonspecific NK cells responding to infection. We speculate that this may be achieved, at least in part, by the well-established function of both Blimp-1 and BTB-ZF proteins (including Zbtb32) in remodeling the chromatin environment at target loci by recruiting histone modifying enzymes, including histone acetylases, histone methyltransferases and histone deacetylases 10, 43, 44 . Perhaps Zbtb32 promotes proliferation in NK cells by suppressing or subverting the ability of Blimp-1 to alter chromatin structure at certain loci such as proproliferative and antiproliferative target genes, and in this way permits the proliferative responses that continue for days after Zbtb32 expression peaks. In support of this idea, a recent study in B cells demonstrated that Zbtb32 and Blimp-1 could physically interact at a protein level and could colocalize at certain loci targeted by Blimp-1 (ref. 42 ). It will be interesting to determine whether Zbtb32 also complexes with Blimp-1 in NK cells, and whether such an interaction might explain the antagonistic relationship between Zbtb32 and Blimp-1 in NK cell proliferation.
The role of Zbtb32 in regulating tumor suppressor and cell cycle pathways in NK cells is consistent with the reported functions of other BTB-ZF family members, both in lymphocytes and in nonhematopoietic cells 9, 10 . For example, LRF has been shown to repress Cdkn1a (also known as p21) and Cdkn2a (also known as p19Arf) in germinal center B cells 45 . Similarly, Bcl-6 facilitates the survival and proliferation of germinal center B cells undergoing class switch recombination and somatic hypermutation by repressing transcription of the tumor suppressor genes TP53 and Prdm1, and the cell-cycle arrest gene CDNK1A (refs. 40,46-49) . Our finding that Zbtb32 regulates NK cell proliferation principally by antagonizing Blimp-1 sheds light on the previously unexplained observation that NK cells could robustly proliferate during infection despite expressing consistently high amounts of Blimp-1 (ref. 41 ), a factor generally recognized to restrain lymphocyte proliferation 40 .
Similar to our findings in MCMV-infected mice, recent studies have described clonal-like NK cell proliferation and long-lived memory-like NK cells in humans infected with human CMV [50] [51] [52] . In as much as proinflammatory cytokines can drive certain adaptive immune properties in human NK cells in vitro 53 , it will be important to determine whether the human Zbtb32 homolog also controls antigenspecific NK cell responses in humans during pathogen infection. Nonetheless, our current findings uncover previously unidentified molecular events that control antigen-specific NK cell responses and may have potential utility in informing therapeutic approaches that harness NK cells in the treatment of human disease. 
